Medicare Enrolled

Dr. Hector Payan, M.D.

Pulmonary Disease · El Paso, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
4305 N MESA ST STE A, El Paso, TX 79902
9155322477
In practice since 2007 (18 years)
NPI: 1093911091 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Payan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Payan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Payan

Dr. Hector Payan is a pulmonary disease in El Paso, TX, with 18 years in practice. Based on federal Medicare data, Dr. Payan performed 1,688 Medicare services across 1,185 unique beneficiaries.

Between the years covered by Open Payments, Dr. Payan received a total of $244,612 from 36 pharmaceutical and/or device companies across 676 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Payan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 26% volume in TX$ $244,612 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,688
Medicare services
Top 26% in TX for pulmonary disease
1,185
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~94 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)438$96$304
Critical care, first 30-74 min396$165$528
Test to measure expiratory airflow and volume changes before and after medication administration120$29$90
Test to examine how well the lungs exchange gases117$41$133
Test to determine lung volumes using sensors113$40$127
Hospital follow-up visit, high complexity112$92$284
New patient office visit (45-59 min)76$119$395
Chest X-ray, 2 views65$25$80
Test for exercise-induced lung stress52$26$81
Office visit, established patient (20-29 min)34$60$215
Initial hospital admission, high complexity29$134$414
Hospital follow-up visit, moderate complexity28$61$189
Office visit, established patient, complex (40-54 min)25$131$426
CT scan of chest, without contrast21$70$328
New patient office visit, complex (60-74 min)19$166$522
Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free16$33$64
Flu vaccine administration14$29$48
Evaluation of use of breathing device13$13$40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$244,612
Total received (2018-2024)
Avg $34,945/year across 7 years
Top 2% in TX for pulmonary disease
36
Companies
676
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$227,446 (93.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,452 (3.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,714 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18,813
2023
$65,931
2022
$53,894
2021
$46,918
2020
$24,725
2019
$23,749
2018
$10,582

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$198,787
Mylan Specialty L.P.
$23,205
Boehringer Ingelheim Pharmaceuticals, Inc.
$6,818
Intuitive Surgical, Inc.
$4,225
Sunovion Pharmaceuticals Inc.
$3,333
AstraZeneca Pharmaceuticals LP
$3,200
ViiV Healthcare Company
$1,600
GENZYME CORPORATION
$501
Grifols USA, LLC
$403
Novartis Pharmaceuticals Corporation
$347
Ethicon Inc.
$250
Regeneron Healthcare Solutions, Inc.
$247
Genentech USA, Inc.
$219
Pulmonx Corporation
$204
Actelion Pharmaceuticals US, Inc.
$198
E.R. Squibb & Sons, L.L.C.
$143
Circassia Pharmaceuticals Inc
$123
SANOFI-AVENTIS U.S. LLC
$100
Philips Electronics North America Corporation
$99
Electromed, Inc.
$87
United Therapeutics Corporation
$78
ABBVIE INC.
$62
Amgen Inc.
$52
Biogen, Inc.
$52
Insmed, Inc.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$40
Advanced Respiratory, Inc
$37
Inogen, Inc.
$24
Horizon Therapeutics plc
$22
Eurofins Viracor, LLC
$17
Chiesi USA, Inc.
$17
Phadia US Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
Gilead Sciences, Inc.
$14
UCB, Inc.
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 93.5% of total payments
Associated products mentioned in payments ›
(7999) SRC Und · AIRSUPRA · ANORO · ANORO ELLIPTA · AVAGE · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BROVANA · Briviact · CHARTIS CATHETER · CLEVIPREX · DUPIXENT · Da Vinci Surgical System · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · GLASSIA · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ION · ImmunoCAP · JARDIANCE · LONHALA MAGNAIR · Life 2000 Ventilation System · Monarch Platform · NUCALA · OFEV · OPDIVO · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Prolastin-C · Prolastin-C Liquid · RAYOS · Respiratoriy Care Undiv · SEEBRI · SMARTVEST · SPINRAZA · STIOLTO RESPIMAT · SYMBICORT · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON · Utibron · Wellcentive Undiv · XOLAIR · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pulmonary disease in TX.

Equivalent to $14,491 per 100 Medicare services performed
Looking for a pulmonary disease in El Paso?
Compare pulmonary diseases in the El Paso area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
13
Per 100K population
1.5
County median income
$58,859
Nearest hospital
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Payan is a clinical cardiology specialist, with above-average Medicare volume (top 26% in TX), and high industry engagement (speaking/promotional, top 2%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Payan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Payan performed 438 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Payan receive payments from pharmaceutical companies?
Yes. Dr. Payan received a total of $244,612 from 36 companies across 676 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Payan's costs compare to other pulmonary diseases in El Paso?
Dr. Payan's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Payan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →